β-内酰胺类抗菌药物的不良反应分析.pdfVIP

  • 1
  • 0
  • 约9.42千字
  • 约 7页
  • 2020-07-13 发布于中国
  • 举报

β-内酰胺类抗菌药物的不良反应分析.pdf

282 例 β-内酰胺类抗菌药物的不良反应分析 潘海燕,凌春燕,朱青 ( 南京大学医学院附属鼓楼医院药剂科, 南京市 210008) 摘要 目的: 了解我院 2009~2010 年β-内酰胺类抗菌药物药品不良反应 ( ADR) 发生 情况, 分析其影响因素, 以促进临床合理用药。方法: 以我院2009~2010 年上报告国家药品 不良反应监测中心的282例β-内酰胺类抗菌药物的ADR 为考察对象,分别从患者年龄、性别、 给药途径、使用药物种类以及临床表现等方面进行统计分析。结果: ADR 涉及β-内酰胺类 抗菌药物共 33 种, 以头孢曲松居首位, 其次为头孢呋辛和氨曲 ; 以静脉途径给药引发的 ADR 最多; 282例 ADR 中, 大于 60 岁的发生率最高, 占28.72%;临床表现以皮肤及其附件损 害最常见。结论: β-内酰胺类抗菌药物发生ADR 与年龄、给药途径等多种因素相关, 应规 范β-内酰胺类抗菌药物的临床应用, 避免或减少 ADR 的发生。 关键词: β-内酰胺类抗菌药物; 药品不良反应; 合理用药 Analysis for 282 Cases of Adverse Drug Reaction of β-lactam Antibiotics Pan Haiyan , Ling Chunyan , Zhu Qing ( Dept.of Pharmacy, The Affiliated Drum Tower Hospital of Medical School of Nanjing University , Nanjing 210008) ABSTRACT Objective: To investigate the reality and affecting factors of adverse drug reactions (ADR ) induced by β-lactam antibiotics in our hospital during 2009~2010, in order to promote the proper use of drug in clinic. Methods :We classified and analyzed 282 cases of adverse drug reaction of β-lactam antibiotics which is reported to National center for ADR Monitoring during 2009~2010, according to the aspects of patients’ age and gender, administration route, species o f drugs and Clinical manifestations. Results: The ADR were caused by a total of 33 species of β-lactam antibiotics agents, among which Ceftriaxone ranked the first and was followed by Cefuroxime and Aztreonam; The most causing route was intravenous administration; of which, those patients’ aged above 60 years accounted for 28.72%;the damage of skin and its annex were the most common clinical manifestations. Conclusion: Multiple factors contributed to the ADR, for example age and administration route. And the clinical application of β-lactam antibiotics of should be regulated to avoid or reduce the occurrence of ADR. KEY WORDS: β -lactam antibiotics; adverse drug reaction; rational admin

文档评论(0)

1亿VIP精品文档

相关文档